Aims To evaluate the relationship between haemostatic and rheological factors and cardiovascular outcome in subjects with angina pectoris in the general population.
Introduction
Patients with angina pectoris are at high risk of future cardiovascular events, particularly acute coronary events. Progression of atherosclerosis within the coronary arteries appears related to recurrent thrombus formation at sites of 'complex' lesions [1] , which may reflect a systemic thrombogenic tendency. Hence, some attention has centred on the role of plasma levels of haemostatic and rheological factors in the clinical outcome of angina pectoris.
In previous studies of selected patient groups, coagulation factors such as fibrinogen [2] [3] [4] [5] , and von Willebrand factor [3] have each been associated with an increased risk of subsequent myocardial infarction, sudden death or all-cause mortality in patients with stable or unstable angina. Disturbed fibrinolysis may also be important in the prediction of an adverse outcome in angina. Elevated tissue plasminogen activator antigen has consistently been shown to predict subsequent cardiac mortality or myocardial infarction [3, [6] [7] [8] , but there are several potential confounding risk factors (e.g. insulin resistance, acute-phase reactions) [9] . Elevated rheological factors may also contribute to the pathogenesis of ischaemic heart disease although, to our knowledge, only two small clinical studies have investigated the predictive value of blood flow abnormalities in unstable angina [10, 11] . To date, the relationship between haemostatic and rheological factors and risk of cardiovascular events has not been examined in subjects with angina pectoris in the general population. It is possible that progression of disease may be different in those with angina detected by random screening in the community compared with hospital-referred patients who are a selected group with differing severity of disease and risk factor levels. Therefore, the aim of the present population-based study was to evaluate the relationship between a range of haemostatic and rheological factors and cardiovascular outcome in subjects with angina pectoris followed up over 5 years. The possible confounding effects of the cardiovascular risk factors, systolic blood pressure, cigarette smoking, serum lipids, body mass index and a history of previous myocardial infarction were also assessed.
Methods

Study population
The Edinburgh Artery Study is a population-based cohort survey of 1592 men and women aged between 55 and 74 years at the time of the baseline examination in 1988. The population was randomly selected by sexspecific 5-year age bands from 11 general practices considered geographically and socio-economically representative of the population of Edinburgh. The response rate was 65%, and follow-up of a 20% sample of non-responders showed no significant bias. Details of the study population and recruitment procedures have been reported previously [12] . The study was approved by the Lothian Health Board Ethics Committee, and informed consent was obtained from each participant.
Clinical investigation
Assessment of all risk factors took place at baseline where participants attended a University clinic. A comprehensive medical examination was carried out, in which a 20 ml sample of fasting blood was taken by trained nurses, following 5 min rest in the supine position. A 12-lead electrocardiogram was performed and coded independently by two observers using the Minnesota coding system [13] . Brachial systolic and diastolic blood pressure was recorded using a random zero sphygmomanometer after 10 min rest. Standing height and weight (without shoes) of participants were also measured. Body mass index was calculated as weight in kilograms divided by the square of the height in metres. Each subject was asked to complete a questionnaire including validated questions concerning personal characteristics, smoking and medical history which included the World Health Organization angina and intermittent claudication questionnaires [14] . Subjects were also asked whether a doctor had ever diagnosed them as suffering from angina or a myocardial infarction (recall diagnosis).
The blood samples were taken between 9.30 am and 12.30 pm to miminize diurnal variation in the levels of biochemical, haemostatic and rheological factors. In the laboratory, serum total cholesterol, high-density lipoprotein cholesterol and serum triglycerides were estimated by a Cobas Bioanalyser (Roche Products). Fibrinogen was measured in citrated plasma by a thrombin-clotting turbidometric method in a centrifugal analyser [15] . Fibrin D-dimer levels were estimated by a commercial enzyme-linked immunosorbent assay (ELISA) supplied by AGEN. von Willebrand factor was also measured by an ELISA (DAKO), as was tissue plasminogen activator antigen (Biopool). Factor VII activity was measured by a chromogenic assay (Kabi Diagnostica). Leucocyte elastase was measured by radioimmunoassay as previously described [16] . Blood and plasma viscosity were measured in a CoulterHarkness capillary viscometer at 37 C and high shear rates. Haematocrit was measured with a Hawksley microcentrifuge and reader.
Five-year follow-up
Subjects were followed up over 5 years to determine the incidence of the following vascular events: myocardial infarction, stroke and coronary artery procedures, including coronary angioplasty and bypass grafting. Notification of deaths was supplied by the United Kingdom National Health Service Central Registry. Information on non-fatal events was obtained from general practitioners, hospital registers, the Information and Statistics Division of the Scottish Home and Health Department, and annual questionnaires to the study participants. Confirmation of all reported events was sought from hospital or general practitioner records. All events were allocated a diagnostic code according to International Classification of Disease, version 9 guidelines. Subjects underwent a second clinical examination during 1993 and 1994 in which they completed a selfadministered questionnaire which included questions on smoking and the World Health Organization angina and claudication questionnaires [14] .
Definition of cardiovascular events
Baseline angina was defined as a positive World Health Organization questionnaire and either recall of a doctor's diagnosis or ECG ischaemia. Baseline myocardial infarction was defined as two of these three indicators: a positive World Health Organization questionnaire, recall diagnosis or diagnostic ECG changes. Subjects were defined as having a cardiovascular event if they had experienced a fatal or non-fatal myocardial infarction or stroke, or had undergone coronary artery bypass grafting or coronary angioplasty during the 5-year follow-up period. Criteria used to define myocardial infarction and stroke were adapted from the American Heart Association [17] . These are described in detail elsewhere [18] . Multiple events of the same type in a subject were recorded only once.
Statistical analysis
Data were analysed on the University of Edinburgh mainframe computer using the SPSS-X and SAS statistical packages. A Student's t-test and chi-squared test were used to assess the significance of differences in the distributions of cardiovascular risk factors, and presence of vascular diseases in the group which had a cardiovascular event in comparison with the no event group. The Wilcoxon signed-rank test was used to calculate differences in median values of each haemostatic and rheological factor between the two groups. In the subsequent multivariate analysis, because of positive skewness in their distributions, square-root transformations were required for von Willebrand factor, tissue plasminogen activator antigen and factor VII levels. Fibrin D-dimer, leucocyte elastase and plasma viscosity results were more heavily skewed and logarithmic transformations were necessary. Pack-years was calculated as a measure of life-time smoking consumption (years of smoking multiplied by the average number of packs smoked per day) and required a square-root transformation. Low-density lipoprotein cholesterol level was calculated from the following Friedewald formula:
Low-density lipoprotein cholesterol =total cholesterol level high-density lipoprotein cholesterol level-(triglycerides level÷5)
Finally, logistic regression was used to calculate ageand sex-adjusted relative risks of having a cardiovascular event for a standard increase of each haemostatic and rheological factor. The relative risks were then further adjusted for the potential confounding effects of packyears, systolic blood pressure, high-density lipoprotein cholesterol, triglycerides, body mass index and baseline myocardial infarction.
Results
Of the 1592 subjects recruited at baseline, 1156 (72·6%) attended the follow-up examination, 131 (8·2%) did not attend the clinic but returned the questionnaire. There were 203 deaths (12·8%) during the 5 years of follow-up. The cause of death was myocardial infarction in 55 subjects, 22 died from a stroke, 12 from other cardiovascular causes and 114 subjects died from non-cardiovascular causes. A total of 207 subjects had evidence of angina at baseline. The primary end-point was any fatal or non-fatal coronary or cerebrovascular event. Non-cardiovascular events were not included in the analysis. Sixty-seven (32·3%) subjects had a fatal or non-fatal cardiovascular event comprising 20 fatal myocardial infarctions, 38 non-fatal myocardial infarctions and 11 fatal or non-fatal strokes, nine had coronary artery bypass grafting and seven subjects underwent coronary angioplasty. There were 18 subjects who had more than one type of cardiovascular event. The remaining 140 subjects identified as having angina at baseline did not suffer an event during follow-up. Table 1 shows that there was a much higher proportion of males in the group of subjects with angina who had an event compared with those who did not (Pc0·001). Levels of high-density lipoprotein cholesterol were decreased by 13·0% in the event group compared with the no event group (Pc0·001) and triglycerides were slightly higher (Pc0·05) in the event group. Among the group who had an event, the prevalence of a previous myocardial infarction was 15·3% greater than in the no event group (Pc0·05). The rest of the variables showed no significant differences between the two groups.
Median levels and interquartile ranges for the haemostatic and rheological factors are shown in Table 2 . With the exception of factor VII, median levels of all the haemostatic factors were higher in subjects with angina who subsequently experienced a new event. The greatest differences between the groups were in levels of tissue plasminogen activator antigen (10·0 ng . ml 1 compared with 7·2 ng . ml 1 , Pc0·001) and in leucocyte elastase (40·3 ng . ml 1 compared with 31 ng . ml 1 , Pc0·01). Of the rheological factors, whole blood viscosity levels were 7·6% higher among subjects who had an event (Pc0·05). Table 3 summarizes the relative risks of developing a new cardiovascular event among subjects with baseline angina for unit increases in each of the haemostatic and rheological factors. After adjusting for age and sex, the relative risk of developing a new cardiovascular event associated with a unit increase in tissue plasminogen activator antigen was statistically significant (RR 1·67, 95% CI, 1·17-2·47; Pc0·01). There was also an significantly increased risk of having an event for a unit increase in leucocyte elastase (RR 1·74, 95% CI, 1·04-2·95; Pc0·05). After further adjustment for cardiovascular risk factors and baseline myocardial infarction, the magnitude of risk of an event increased for both tissue plasminogen activator antigen and leucocyte elastase. This reflected negative correlations with high-density lipoprotein cholesterol (r=0·38; P=0·0001 and r= 0·10; P=ns, respectively). Figures 1 and 2 show the relative risk for an event across tertiles of tissue plasminogen activator antigen and leucocyte elastase levels after multi-adjustment. Subjects with values of tissue plasminogen activator antigen in the second and third tertiles had increased relative risks of 4·36 (95% CI, 1·58-13·41; Pc0·01) and 7·92 (95% CI, 2·50-28·39; Pc0·001), respectively, when compared with the lowest tertile. A similar pattern for leucocyte elastase level was found, with the highest relative risk found in the top tertile (RR 4·33, 95% CI, 1·77-11·25; Pc0·05).
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Discussion
To our knowledge, this is the first prospective study of the relationship between haemostatic and rheological factors and cardiovascular events in subjects with angina pectoris in the general population. The results showed that high levels of tissue plasminogen activator antigen and leucocyte elastase (a marker of leucocyte activation) were each associated with an increased risk of future cardiovascular events. Furthermore, these associations were independent of previous myocardial infarction, as a measure of severity of baseline ischaemic heart disease, and of cardiovascular risk factors implicated in the insulin resistance syndrome [19] , a condition which is also associated with the development of angina [20] . Levels of other haemostatic or rheological factors, although raised in individuals who experienced a new cardiovascular event, had no significant prognostic value on multivariate analysis.
Our data support the findings of the majority of clinical studies investigating tissue plasminogen activator antigen in patients with angina pectoris. Both the Angina Prognosis Study in Stockholm [7] and the Umea hospital study [8] reported that tissue plasminogen activator antigen was a strong predictor of cardiovascular death and myocardial infarction in patients with stable Wilcoxon signed-rank test used to examine differences in distribution between event group and no event group: *Pc0·05; **Pc0·01; ***Pc0·001.
angina or more severe angina at rest. However, the largest of the angina studies, the European Concerted Action on Thrombosis and Disabilities (ECAT) study found that tissue plasminogen activator antigen was no longer predictive of incident coronary events after adjustment for a combination of variables associated with insulin resistance, inflammation and endothelial damage [9] . In the present study, most of the covariates chosen were related to insulin resistance (lifetime smoking, systolic blood pressure, levels of triglycerides or high-density lipoprotein cholesterol, and body mass index) and had little influence on the tissue plasminogen activator antigen effect. Adjustment for these variables alone in the ECAT Study also had a minimal effect on the relationship between tissue plasminogen activator and outcome. However, it is unclear whether tissue plasminogen activator antigen has any direct effect on thrombotic risk or whether raised levels are a result of Table 3 Relative risks (95% CI) of cardiovascular events in subjects with angina pectoris for unit increase in haemostatic and rheological factors adjusting for cardiovascular risk factors and baseline myocardial infarction
0 ·73 (0·48-1·09) †Unit increase in haemostatic and rheological factors equates approximately with one standard deviation or one unit on a logarithmic scale. ‡a: Analysis adjusted for age and sex: b: Analysis adjusted for age, sex, systolic blood pressure, body mass index, triglyceride level (as Ln), high-density lipoprotein cholesterol, cigarette smoking and baseline myocardial infarction. *Pc0·05; **Pc0·01. 
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inflammation and endothelial dysfunction in response to existing or progressing atherosclerosis. Release of leucocyte elastase is indicative of white blood cell activation which may have important effects on blood flow in the micro-circulation due to oxygenmetabolite related ischaemia [21] . Activated leucocytes, due to their relative rigidity may also cause microvascular obstruction and hence disturbances to microvascular flow [22] . Our finding that leucocyte elastase was significantly associated with subsequent cardiovascular events also suggests a role for the substance in thrombosis in the presence of a given degree of arterial narrowing, possibly through interactions with platelets and coagulation factors [23] . Elevations in leucocyte elastase may also be related to the chronic inflammatory activity associated with atherosclerosis. One mechanism through which white cell activation may cause progression of atherosclerotic disease is thought to be by macrophage infiltration into the endothelium, release of lytic enzymes and subsequent plaque rupture [24] . There is also evidence of a relationship between white blood cells and activation of coagulation pathways through increased expression of tissue factor in circulating white blood cells and those found within atherosclerotic plaques in patients with angina. This may subsequently contribute to fibrin or thrombus formation within the coronary arteries. Therapeutic possibilities to reduce leucocyte activation (as measured by elastase release) include reducing cigarette smoking [26] and use of antioxidants [27] . Studies of the effect of smoking cessation and antioxidants on elastase levels in angina patients merit consideration.
Both fibrinogen and fibrin D-dimer levels are significantly raised in patients with unstable angina compared with healthy controls [28] and fibrinogen has been found to be a significant predictor of subsequent death and myocardial infarction in patients with severe angina [2] [3] [4] [5] . Elevations in fibrinogen have also been related to ischaemic episodes in hospitalized patients with unstable angina [29] . In the present study, we were unable to establish any relationship between fibrinogen or fibrin D-dimer and subsequent cardiovascular events. The discrepancy between our findings and the other studies may reflect their different outcomes, inclusion criteria, small number of events and patient selection. The great majority of the subjects in the present study were classified as having stable angina, and probably had less severe disease at baseline. There are some reports that fibrinogen is more strongly related to unstable than to stable angina, which may reflect the role of fibrinogen in active thrombus formation [28] . It is also possible that elevated fibrinogen may have a stronger short-term prognostic significance on outcome in severe angina, with follow-up periods of only 5 months [4] , 2 years [3] , and 3 years [5] in the previous studies compared with 5 years in the present study.
The release of von Willebrand factor from endothelial cells is thought to represent leakage from viable endothelial cells rather than endothelial damage [30] . von Willebrand factor was also not associated with an adverse outcome in the present study, although this may have been due to the small numbers of subjects and cardiovascular events. Conversely, the ECAT study reported that von Willebrand factor was associated with approximately twice the increase in risk of coronary events with increasing levels [3] . Further analysis, however, showed that when adjustment was made for markers of inflammation (fibrinogen and C-reactive protein), von Willebrand factor was no longer predictive of outcome. This suggests that von Willebrand factor release may be related to interactions between inflammatory processes and endothelial dysfunction in the progression of ischaemic heart disease.
Although whole blood viscosity was significantly increased in those who progressed to future cardiovascular events compared with those who had no event, neither this variable, nor its determinants (haematocrit, plasma viscosity) were significant predictors of future events on multivariate analysis. The significantly higher levels of blood viscosity in the event group could be explained by a decrease in red blood cell deformability, a major determinant of blood viscosity. Whereas previous studies have shown that angina, particularly unstable angina, is associated with increases in blood and plasma viscosity and red cell aggregation [10, 11, 31, 32] , little data are available on the prognostic significance of these variables. One prospective study found that raised plasma viscosity and red cell aggregation identified patients who developed an acute myocardial infarction during 6 months of follow-up or had surgical treatment for unstable angina. This suggests that disturbed blood flow may be important in the development of thrombosis [33] .
Results of this epidemiological study should be interpreted with caution. These findings were based on a relatively low number of events and larger studies are needed to confirm these associations. Subjects with symptomatic disease may change their lifestyle or undergo treatment to modify certain risk factors and thus their 'true' levels may have changed. Moreover, although in the multivariate analysis adjustment was made for previous myocardial infarction and common cardiovascular risk factors, confounding by other risk factors may have occurred.
In conclusion, results from this population-based study suggest that tissue plasminogen activator antigen and leucocyte elastase may be important risk factors in the development of atherothrombotic events in individuals with angina pectoris. These relationships appear to be independent of risk factors associated with the insulin resistance syndrome, and also of previous myocardial infarction. Further studies are required to determine the relationships between inflammatory, metabolic and environmental markers and these variables in order to assess the possibility of therapeutic intervention among patients with angina pectoris.
